[{"orgOrder":0,"company":"Hi-Q Marine Biotech","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"TAIWAN","productType":"Dietary Supplement","year":"2020","type":"Inapplicable","leadProduct":"Fucoidan","moa":"Undisclosed","graph1":"Oncology","graph2":"Phase II","graph3":"Hi-Q Marine Biotech","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Hi-Q Marine Biotech \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"Hi-Q Marine Biotech \/ Undisclosed"},{"orgOrder":0,"company":"Marinova Pty Ltd","sponsor":"Nutrasource | University of South Carolina","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"AUSTRALIA","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Fucoidan","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Marinova Pty Ltd","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Marinova Pty Ltd \/ Nutrasource | University of South Carolina","highestDevelopmentStatusID":"1","companyTruncated":"Marinova Pty Ltd \/ Nutrasource | University of South Carolina"}]

Find Clinical Drug Pipeline Developments & Deals for Fucoidan

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Marinova Pty Ltd

                          Country arrow
                          The MedTech Conference
                          Not Confirmed

                          Marinova Pty Ltd

                          Country arrow
                          The MedTech Conference
                          Not Confirmed

                          Details : Fucoidan is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          March 14, 2022

                          Lead Product(s) : Fucoidan

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : Nutrasource | University of South Carolina

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          Hi-Q Marine Biotech

                          Country arrow
                          Fall Technical Meeting
                          Not Confirmed

                          Hi-Q Marine Biotech

                          Country arrow
                          Fall Technical Meeting
                          Not Confirmed

                          Details : Fucoidan is a Dietary Supplement drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Squamous Cell Carcinoma of Head and Neck.

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          October 22, 2020

                          Lead Product(s) : Fucoidan

                          Therapeutic Area : Oncology

                          Highest Development Status : Phase II

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank